Keyphrases
Potential Treatments
100%
Parkinson's Disease
100%
Neural Substrates
100%
Levodopa-induced Dyskinesia
100%
Substrate Treatment
100%
Clinical Features
20%
Disease Stage
20%
Deep Brain Stimulation
20%
Stimulation Treatment
20%
Motor Function
20%
Serotonin
20%
Advanced Stage
20%
Neurotransmitter Systems
20%
Neurodegenerative Diseases
20%
Glutamate
20%
Muscle Contraction
20%
Motor Disorders
20%
Basal Ganglia
20%
Levodopa
20%
Can Effect
20%
Grief
20%
Downstream Effects
20%
Aminobutyric Acid
20%
Blinking
20%
Substantia Nigra Pars Compacta
20%
Cognitive Correlates
20%
Dopaminergic Neuron Loss
20%
Prolonged Treatment
20%
Repetitive Movements
20%
Non-dopaminergic
20%
Psychopharmacological
20%
Neuroscience
Parkinson's Disease
100%
L-DOPA
100%
Dyskinesia
100%
Deep Brain Stimulation
16%
Serotonin
16%
Neurotransmitter
16%
Neurodegenerative Disorder
16%
Glutamic Acid
16%
Stereotypic Movement Disorder
16%
Basal Ganglia
16%
Dopaminergic
16%
Gamma-Aminobutyric Acid
16%
Substantia Nigra Pars Compacta
16%
Grief
16%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
100%
Levodopa-Induced Dyskinesia
100%
Diseases
20%
Clinical Feature
20%
Serotonin
20%
Neurotransmitter
20%
Degenerative Disease
20%
Glutamic Acid
20%
Motor Dysfunction
20%
Dopamine Receptor Stimulating Agent
20%
Levodopa
20%
4 Aminobutyric Acid
20%